NORDIC BIOTECH GENERAL PARTNER ApS
CVR 26270367 · Private limited company (ApS) · In voluntary liquidation
NORDIC BIOTECH GENERAL PARTNER ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry ikke-finansielle holdingselskaber. The company is no longer active (status: in voluntary liquidation). 20 annual reports have been published. The latest annual report (31 Dec 2024) shows equity of DKK 1.0m and a net result of DKK 67k.
Company details
- CVR number
- 26270367
- Status
- In voluntary liquidation
- Company type
- Private limited company (ApS)
- Founded
- Address
- c/o NB Capital ApS, Strandvejen 125
2900 Hellerup - Municipality
- København
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 125k
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 23 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 97.9% |
| Current ratio | 4,691% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 114 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2024 | 2023 |
|---|---|---|
| Gross profit | DKK 40k | DKK 7,687 |
| Net profit | DKK 67k | DKK 35k |
| Equity | DKK 1.0m | DKK 969k |
| Total assets | DKK 1.1m | DKK 995k |
| Cash | DKK 1.1m | – |
| Short-term debt | DKK 23k | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 179 | ||
| 1 Jan 2023 – 31 Dec 2023 | 165 | ||
| 1 Jan 2022 – 31 Dec 2022 | 181 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 166 | ||
| 1 Jan 2019 – 31 Dec 2019 | 155 | ||
| 1 Jan 2018 – 31 Dec 2018 | 148 | ||
| 1 Jan 2017 – 31 Dec 2017 | 163 | ||
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 150 | ||
| 1 Jan 2014 – 31 Dec 2014 | 150 | ||
| 1 Jan 2013 – 31 Dec 2013 | 174 | ||
| 1 Jan 2012 – 31 Dec 2012 | 147 | ||
| 1 Jan 2011 – 31 Dec 2011 | 153 | ||
| 1 Jan 2010 – 31 Dec 2010 | 75 | ||
| 1 Jan 2009 – 31 Dec 2009 | 84 | ||
| 1 Jan 2008 – 31 Dec 2008 | 91 | ||
| 1 Jan 2007 – 31 Dec 2007 | 87 | ||
| 1 Jan 2006 – 31 Dec 2006 | 84 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Christian Karsten Hansen | ||
| CEO | Florian Schønharting | ||
| Board | Claus Tycho Bræstrup | ||
| Board | Lars Grønborg Eskesen | ||
| Board | Maja Kirstine Elsøe | ||
| Board | Matthew Daniel Perry | ||
| Board | Christian Karsten Hansen | ||
| Board | Florian Schønharting | ||
| Owner (25%) | C. HANSEN INVEST ApS | Current | |
| Owner (67%) | TECH GROWTH INVEST ApS | Current | |
| Owner (33%) | TECH GROWTH INVEST ApS | ||
| Owner (25%) | BVF/Nexgen Investments, LP | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | EY Danmark A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Founder | TECH GROWTH INVEST ApS | Current | |
| Founder | C. HANSEN INVEST ApS | Current | |
| Founder | H. LUNDBECK A/S | Current | |
| Founder | VækstFonden | Current | |
| Founder | BVF/NexGen Investments, L.P | Current |
The CEOs' other companies
Christian Karsten Hansen – 23 other companies, of which 1 bankrupt
- H PHARMACEUTICALS GENERAL PARTNER ApS Bankrupt 7 Aug 2012
- C. HANSEN INVEST ApS Active
- CKH INVEST ApS Opløst
- CURALOGIC A/S Opløst
- ENTROP PHARMA ApS Opløst
- FORWARD PHARMA A/S Opløst
- HYSCITE DISCOVERY A/S Compulsorily dissolved
- MAXYGEN ApS Opløst
- NB PUBLIC EQUITY INVEST ApS Active
- NORDIC BIOTECH ADVISORS ApS Active
- NORDIC BIOTECH GENERAL PARTNER II ApS Opløst
- NORDIC BIOTECH INCENTIVE ApS Opløst
- NORDIC BIOTECH INCENTIVE II ApS Opløst
- NUEVOLUTION A/S Active
- OSTEOLOGIX ApS Opløst
- POALIS A/S Opløst
- PROFOUND INVEST A/S Opløst
- ParaTech ApS Active
- RODDAX ApS Opløst
- ROSE PHARMA A/S Compulsorily dissolved
- SPREE PHARMA A/S Opløst
- SUNIN GENERAL PARTNER ApS Opløst
- TECH GROWTH INVEST ApS Active
Florian Schønharting – 26 other companies, of which 1 bankrupt
- H PHARMACEUTICALS GENERAL PARTNER ApS Bankrupt 7 Aug 2012
- AKTIESELSKABET BI BIOMEDICINSK VENTURE II Opløst
- BANKINVEST PRIVATE EQUITY A/S Opløst
- CURALOGIC A/S Opløst
- ENTROP PHARMA ApS Opløst
- FORWARD PHARMA A/S Opløst
- Forward Pharma FA ApS Opløst
- Holdingselskabet af 1 januar 2016 ApS Active
- NB FP INVESTMENT GENERAL PARTNER ApS Opløst
- NB FP INVESTMENT SLP ApS Opløst
- NB PUBLIC EQUITY INVEST ApS Active
- NEXGEN VENTURES ApS Compulsorily dissolved
- NORDIC BIOTECH ADVISORS ApS Active
- NORDIC BIOTECH GENERAL PARTNER II ApS Opløst
- NORDIC BIOTECH INCENTIVE ApS Opløst
- NORDIC BIOTECH INCENTIVE II ApS Opløst
- NORDIC BIOTECH PRIVATE INVESTORS ApS Opløst
- NUEVOLUTION A/S Active
- OSTEOLOGIX ApS Opløst
- POALIS A/S Opløst
- PROFOUND INVEST A/S Opløst
- ROSE PHARMA A/S Compulsorily dissolved
- SPREE PHARMA A/S Opløst
- TECH GROWTH INVEST ApS Active
- TEGI ApS Opløst
- VELOXIS PHARMACEUTICALS A/S Active
Address history (3 moves)
| c/o NB Capital ApS, Strandvejen 125, 2900 Hellerup | |
| c/o NB Capital ApS, Østergade 24A, 1. tv, 1100 København K | |
| Østergade 5, 3., 1100 København K | |
| c/o Lindh Stabell Horten A/S, Ved Stranden 18, 1012 København K |
Other companies at the same address
- E & S - Consult IVS Bankrupt
- Redline Media Group ApS Bankrupt
- VIA Telegroup Danmark ApS Bankrupt
- AL Copenhagen A/S Active
- AP Management ApS Active
- AarhusGeoSoftware ApS Opløst
- Administrationsselskabet i "Buen" ApS Active
- Andersen & Friends Holding ApS Active
- BAKKEDAL INVEST ApS Opløst
- BESTYRELSESPOSTEN ApS Opløst
- BIOGEN (DENMARK) A/S Active
- Biofuel Technology Holding ApS Active
- Borderless Denmark Holdings ApS Active
- CAPNORDIC HOLDING ApS Active
- CKIT HOLDING ApS Active
- CKIT Software ApS Opløst
- COHAMI HOLDING ApS Opløst
- CREDITSAFE DENMARK ApS Active
- Clarify Commerce ApS Active
- Classic Maritime ApS Active
- CoreWeave SVL01 ApS Active
- Crone Burmeister Adv. ApS Active
- CyberOne ApS Active
- Dansk Demetra ApS Active
- Davy DebtCo ApS Active
Similar companies in København
- ANTECH INVEST A/S København K
- NIELS BUCHHOLST A/S København Ø
- METROPOLITAN HOLDING ApS København S
- JOOST HOLDING ApS København K
- TENNECO HOLDINGS DANMARK ApS København V
- GENUA A/S København K
- AHM AF 1997 HOLDING ApS Nordhavn
- T. K. BOESEN HOLDING ApS København K
- Hallerup Group ApS København K
- B. EYDE-JØRGENSEN ApS København V
- BRØDR. JØRGENSEN HOLDING A/S København K
- GULDBERG EJENDOMS- OG INVESTERINGSSELSKAB A/S København N
Questions and answers about NORDIC BIOTECH GENERAL PARTNER ApS
Has NORDIC BIOTECH GENERAL PARTNER ApS gone bankrupt?
No, NORDIC BIOTECH GENERAL PARTNER ApS is not registered as bankrupt in the CVR register. Its status is: in voluntary liquidation.
Who is the auditor of NORDIC BIOTECH GENERAL PARTNER ApS?
NORDIC BIOTECH GENERAL PARTNER ApS most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was NORDIC BIOTECH GENERAL PARTNER ApS founded?
NORDIC BIOTECH GENERAL PARTNER ApS was founded on 28 September 2001.
What is the equity of NORDIC BIOTECH GENERAL PARTNER ApS?
Equity was DKK 1.0m according to the annual report for the period ending 31 December 2024.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.